Gene · 5798
Papers3,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Associations of body weight and COVID-19 with autoimmunity in pediatric new-onset type 1 diabetes: results from the prospective DPV registry. | BMJ Open Diabetes Res Care | 2026 | 41545230 | PubTator, text mining | PubMed |
| Transmembrane Protein TMEM59L Modulates 5-FU Resistance via PTPRN-Mediated DNA Damage Repair in Colorectal Cancer. | Cancer Rep (Hoboken) | 2026 | 41543046 | PubTator, text mining | PubMed |
| Correction: Circulating senescence-associated secretory phenotype factors across the stages of type 1 diabetes in a cross-sectional cohort. | Sci Rep | 2026 | 41535331 | PubTator, text mining | PubMed |
| Targeted analysis of whole exome sequencing in Thai patients with neonatal diabetes. | Hum Genet | 2026 | 41498801 | PubTator, text mining | PubMed |
| GADA as a biomarker for type 1 diabetes. | Clin Chim Acta | 2026 | 41371328 | PubTator, text mining | PubMed |
| Generalizability of Progression Risk in the TN-10 Trial to a European Population With or Without a First-Degree Relative With Type 1 Diabetes. | Diabetes Care | 2026 | 41118628 | PubTator, text mining | PubMed |
| 5Z-7-Oxozeanol Isolated from the Fungus Curvularia sp. MDCW-1060 Inhibits the Proliferation of MDA-MB-231 Cells via the PI3K-Akt and MAPK Pathways. | Mar Drugs | 2025 | 41295383 | PubTator, text mining | PubMed |
| PTPRN promotes glioma cell proliferation, migration, and invasion by regulating the EMT pathway. | Int J Clin Exp Pathol | 2025 | 41244147 | PubTator, text mining | PubMed |
| Malnutrition Modulated Diabetes: A Variant of Type-1 Diabetes or Hybrid Diabetes and Not Type-5 Diabetes'. | Indian J Endocrinol Metab | 2025 | 41229725 | PubTator, text mining | PubMed |
| Islet autoimmunity in young First Nations women with prediabetes and type 2 diabetes. | Diabetes Res Clin Pract | 2025 | 41173196 | PubTator, text mining | PubMed |
A case of slowly progressive type 1 diabetes accompanied by positivity for a single islet cell antibody, initially suspected to be childhood-onset type 2 diabetes or maturity-onset diabetes of the young. | Diabetol Int | 2025 | 41111582 | PubTator, text mining | PubMed |
| Identification of Peripheral Blood Endotypes Associated With Age in Pediatric Type 1 Diabetes. | Pediatr Diabetes | 2025 | 41049864 | PubTator, text mining | PubMed |
| Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells. | PLoS One | 2025 | 40986633 | PubTator, text mining | PubMed |
| IL17RA and IL21R polymorphisms influence type 1 diabetes predisposition and autoimmune phenotypes. | Front Endocrinol (Lausanne) | 2025 | 40979706 | PubTator, text mining | PubMed |
| Molecular requirements for mammalian crinophagy highlight a key role for Ca2+-dependent Munc13-4. | Res Sq | 2025 | 40951263 | PubTator, text mining | PubMed |
| Structural Homology and Electrostatic Potential Comparisons of Epitope Pair Candidates for Molecular Mimicry Triggering of Type 1 Diabetes Mellitus. | bioRxiv | 2025 | 40950207 | PubTator, text mining | PubMed |
| Improving phase 2/3 trials with an enhanced 2-in-1 adaptive design. | Contemp Clin Trials Commun | 2025 | 40822703 | PubTator, text mining | PubMed |
| Misdiagnosis of diabetic ketoacidosis: a case report. | J Med Case Rep | 2025 | 40818960 | PubTator, text mining | PubMed |
| Severe Metabolic Acidosis Related to Simultaneous Use of Metformin and Dapagliflozin: A Case Report. | Cureus | 2025 | 40761987 | PubTator, text mining | PubMed |
| Ketosis-prone Diabetes as a Presentation of New-onset Diabetes in a Patient With Spinal Muscular Atrophy Type III. | JCEM Case Rep | 2025 | 40741597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5798/papers?page=3